Ligand-Activated Interaction of PPARδ With C-Myc Governs the Tumorigenicity of Breast Cancer

International Journal of Cancer - United States
doi 10.1002/ijc.31864
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression Through C-Myc Upregulation

PLoS ONE
Multidisciplinary
2013English

C-Myc Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality With TRAIL.

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Ligand-Activated PPARδ Inhibits UVB-induced Senescence of Human Keratinocytes via PTEN-mediated Inhibition of Superoxide Production

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2012English

Plasma C-Myc Level Manifesting as an Indicator in Progression of Breast Cancer

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

Abnormal FHIT Gene Transcript and C-Myc and C-erbB2 Amplification in Breast Cancer.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2002English

Parvin- Inhibits Breast Cancer Tumorigenicity and Promotes CDK9-Mediated Peroxisome Proliferator-Activated Receptor Gamma 1 Phosphorylation

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2007English

Pharmacological Targeting of MYC-regulated IRE1/XBP1 Pathway Suppresses MYC-driven Breast Cancer

Journal of Clinical Investigation
Medicine
2018English

Importance of Copy Number Alterations of FGFR1 and C-Myc Genes in Triple Negative Breast Cancer

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2019English

Breast Cancer: Rank Ligand Inhibition

Breast Care
SurgeryOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy